Ballesta AM - Search Results

1

C-erbB-2 oncoprotein in the sera and tissue of patients with breast cancer. Utility in prognosis.

Molina R, Jo J, Filella X, Zanon G, Pahisa J, Muñoz M, Farrus B, Latre ML, Gimenez N, Hage M, Estape J, Ballesta AM. Molina R, et al. Among authors: ballesta am. Anticancer Res. 1996 Jul-Aug;16(4B):2295-300. Anticancer Res. 1996. PMID: 8694559

2

Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC.

Molina R, Torres MD, Moragas M, Filella X, Jo J, Giménez N, Traserra J, Ballesta AM. Molina R, et al. Among authors: ballesta am. Anticancer Res. 1995 Mar-Apr;15(2):479-84. Anticancer Res. 1995. PMID: 7763026

3

Mucin-like carcinoma-associated antigen (MCA) in tissue and serum of patients with breast cancer: clinical applications in prognosis and disease monitoring.

Molina R, Jo J, Filella X, Zanon G, Grau JJ, Joseph J, Bedini JL, Biete A, Ballesta AM. Molina R, et al. Among authors: ballesta am. Int J Biol Markers. 1993 Apr-Jun;8(2):113-23. doi: 10.1177/172460089300800208. Int J Biol Markers. 1993. PMID: 8366294

4

Prognostic significance of SCC antigen in the serum of patients with head and neck cancer.

Molina R, Torres MD, Moragas M, Perez-Villa J, Filella X, Jo J, Farrus B, Giménez N, Traserra J, Ballesta AM. Molina R, et al. Among authors: ballesta am. Tumour Biol. 1996;17(2):81-9. doi: 10.1159/000217970. Tumour Biol. 1996. PMID: 8658017

5

TPA prognostic value in superficial bladder cancer.

Filella X, Menendez V, Molina R, Alcover J, Carretero P, Ballesta AM. Filella X, et al. Among authors: ballesta am. Anticancer Res. 1996 Jul-Aug;16(4B):2173-5. Anticancer Res. 1996. PMID: 8694539

6

Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.

Molina R, Jo J, Zanón G, Filella X, Farrus B, Muñoz M, Latre ML, Pahisa J, Velasco M, Fernandez P, Estapé J, Ballesta AM. Molina R, et al. Among authors: ballesta am. Br J Cancer. 1996 Oct;74(7):1126-31. doi: 10.1038/bjc.1996.501. Br J Cancer. 1996. PMID: 8855986 Free PMC article.

7

Serum levels of C-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases.

Molina R, Jo J, Filella X, Bruix J, Castells A, Hague M, Ballesta AM. Molina R, et al. Among authors: ballesta am. Tumour Biol. 1997;18(3):188-96. doi: 10.1159/000218029. Tumour Biol. 1997. PMID: 9143415

8

p53 oncoprotein as a prognostic indicator in patients with breast cancer.

Molina R, Segui MA, Climent MA, Bellmunt J, Albanelll J, Fernandez M, Filella X, Jo J, Gimenez N, Iglesias E, Miralles M, Alonso C, Peiro G, Perez-Picañol E, Ballesta AM. Molina R, et al. Among authors: ballesta am. Anticancer Res. 1998 Jan-Feb;18(1B):507-11. Anticancer Res. 1998. PMID: 9580543

9

Tumor markers in response monitoring and prognosis of non-small cell lung cancer: preliminary report.

Viñolas N, Molina R, Galán MC, Casas F, Callejas MA, Filella X, Grau JJ, Ballesta AM, Estape J. Viñolas N, et al. Among authors: ballesta am. Anticancer Res. 1998 Jan-Feb;18(1B):631-4. Anticancer Res. 1998. PMID: 9584045 Clinical Trial.

10

c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value.

Molina R, Jo J, Filella X, Zanon G, Pahisa J, Mu noz M, Farrus B, Latre ML, Escriche C, Estape J, Ballesta AM. Molina R, et al. Among authors: ballesta am. Breast Cancer Res Treat. 1998 Sep;51(2):109-19. doi: 10.1023/a:1005734429304. Breast Cancer Res Treat. 1998. PMID: 9879773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters